SG Americas Securities LLC Grows Stock Position in OrthoPediatrics Corp. (NASDAQ:KIDS)

SG Americas Securities LLC grew its position in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) by 175.0% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 20,039 shares of the company's stock after acquiring an additional 12,753 shares during the period. SG Americas Securities LLC owned about 0.08% of OrthoPediatrics worth $494,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. GAMMA Investing LLC boosted its stake in shares of OrthoPediatrics by 4,618.2% in the first quarter. GAMMA Investing LLC now owns 10,616 shares of the company's stock worth $261,000 after acquiring an additional 10,391 shares during the last quarter. Wellington Management Group LLP boosted its stake in OrthoPediatrics by 20.2% during the 4th quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company's stock worth $24,601,000 after purchasing an additional 178,078 shares during the last quarter. AWM Investment Company Inc. boosted its stake in OrthoPediatrics by 14.8% during the 4th quarter. AWM Investment Company Inc. now owns 516,794 shares of the company's stock worth $11,979,000 after purchasing an additional 66,779 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of OrthoPediatrics by 76.8% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 19,863 shares of the company's stock worth $460,000 after buying an additional 8,631 shares in the last quarter. Finally, Point72 Asset Management L.P. acquired a new stake in shares of OrthoPediatrics in the fourth quarter valued at about $7,450,000. Hedge funds and other institutional investors own 69.05% of the company's stock.

OrthoPediatrics Price Performance

KIDS traded down $0.40 on Friday, hitting $21.37. 245,620 shares of the company were exchanged, compared to its average volume of 200,417. OrthoPediatrics Corp. has a fifty-two week low of $19.52 and a fifty-two week high of $35.99. The firm has a market capitalization of $519.08 million, a P/E ratio of -12.21 and a beta of 1.08. The business's fifty day moving average is $21.38 and its 200 day moving average is $23.08. The company has a debt-to-equity ratio of 0.21, a quick ratio of 2.99 and a current ratio of 6.19.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by ($0.13). OrthoPediatrics had a negative net margin of 19.15% and a negative return on equity of 7.03%. The business had revenue of $52.41 million during the quarter, compared to analysts' expectations of $51.68 million. As a group, sell-side analysts anticipate that OrthoPediatrics Corp. will post -0.93 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on KIDS. Truist Financial dropped their price target on shares of OrthoPediatrics from $26.00 to $24.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Needham & Company LLC reissued a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Thursday, May 8th. Wall Street Zen cut OrthoPediatrics from a "hold" rating to a "sell" rating in a research report on Friday, June 6th. Piper Sandler reduced their price target on shares of OrthoPediatrics from $40.00 to $30.00 and set an "overweight" rating for the company in a research report on Thursday, May 8th. Finally, Lake Street Capital started coverage on OrthoPediatrics in a research report on Monday, April 7th. They set a "buy" rating and a $37.00 price objective for the company. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $35.83.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.